Sale!

Mounjaro 5mg KwikPen

Name: Mounjaro 5mg KwikPen
Brand: LILLY
SKU: 648
Availability: InStock

TIRZEPATIDE INJECTION 5MG

2-8* C

MRP	:	~~MRP ₹16,406.25~~
Price	:	₹15,000.00
You Save	:	₹1,406.25 (8.57%)

1 Pre-filled Pen(s)

SKU: 648 Category: Diabetes Tag: diabetes Brand: LILLY

Mounjaro 5mg KwikPen is a prescription medication intended for once-weekly subcutaneous injection to assist adults with type 2 diabetes in effectively managing their blood sugar levels.

Its active component, tirzepatide, acts as a dual receptor agonist, targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This positions Mounjaro within a newer category of antidiabetic medications known as incretin mimetics, which replicate the function of natural gut hormones that play a role in blood sugar regulation.

Mounjaro is meant to be used when lifestyle changes such as diet and exercise alone do not sufficiently control blood glucose levels. The KwikPen device is a prefilled, multi-dose pen designed for easy self-administration at home. Each pen contains four fixed doses of the specified strength, meaning a 5mg pen contains a total of 20mg of tirzepatide (4 doses x 5mg), with each dose being 0.6 ml. Patients are instructed to inject one dose weekly, making each pen last for one month. This convenient dosing regimen aids in maintaining stable blood levels and streamlines treatment.

This medication is specifically approved for type 2 diabetes and should not be utilized for type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should refrain from using this treatment. Always administer Mounjaro under the guidance of a qualified healthcare professional.

Improving blood sugar control in adults with type 2 diabetes mellitus
Used in combination with diet and exercise
May be used alone or with other diabetes medications

Tirzepatide functions by imitating two essential gut hormones, GIP and GLP-1, which are vital for glucose regulation:

Encouraging insulin release when blood sugar levels rise.

Decreasing glucose production in the liver.

Delaying gastric emptying, which extends the sensation of fullness and may lead to a reduction in food consumption.

Collectively, these effects assist in sustaining more consistent blood glucose levels during the day, aiding in better glycemic control.

Similar to many diabetes treatments, this injection can interact with specific other medications, potentially impacting its effectiveness or heightening the risk of side effects. It is crucial to inform your doctor about all the medications you are taking, particularly:

Insulin or sulfonylureas: The combination of these can elevate the risk of hypoglycemia, necessitating possible dose modifications.

Oral contraceptives: Tirzepatide might diminish the efficacy of birth control pills due to delayed gastric emptying, so alternative or supplementary contraceptive methods are recommended.

Warfarin: This medication may influence INR levels, requiring careful monitoring if you are on anticoagulants.

Diuretics or antihypertensives: There is a risk of sudden blood pressure drops, especially if dehydration occurs from nausea or vomiting.

Thyroid medications: Caution is advised for patients with a history of thyroid conditions, particularly medullary thyroid carcinoma.

Always keep a list of your medications handy to share with your doctor or pharmacist to avoid serious drug interactions.

Administer once a week into your abdomen, thigh, or upper arm, with or without food, at any time during the day. Always aim to use it on the same day each week.
Remember:

Each pen contains four doses of its specified strength (5mg pen = total 20mg in pen).

One dose per week indicates that one pen provides a one-month supply.

Do not share your pen.

Alternate injection sites to prevent skin thickening.

Keep any unused KwikPens stored in the refrigerator at a temperature between 2°C and 8°C — do not place them in the freezer.

They remain usable until the expiration date as long as they are kept refrigerated.

Avoid freezing the pen. If it has been frozen, dispose of it in a sharps disposal container.

Keep it in its original carton to shield it from light.
After You Begin Using a KwikPen

You may store it at room temperature (up to 30°C) for a maximum of 30 days.

Ensure it is kept away from direct heat and sunlight.

Dispose of it 30 days after the initial use, even if there is still some medication remaining.

Additionally, discard it after you have completed all 4 weekly doses, in a sharps disposal container.

Common Side Effects:

Nausea
Vomiting
Diarrhea
Constipation
Decreased appetite
Injection site reactions (redness, itching)

Serious Side Effects:

Pancreatitis (severe abdominal pain)
Gallbladder issues (pain in the upper right abdomen)
Allergic reactions (rash, swelling, difficulty breathing)
Kidney problems due to dehydration from vomiting or diarrhea
Thyroid tumors (rare but serious; watch for neck swelling or hoarseness)

Mounjaro 5mg KwikPen

Fact Box of Mounjaro 5mg KwikPen

Disclaimer

mounjaro 5mg

2000+ products

Secure Payment

Easy Return

Company

Speciality Drugs

More Info

Mounjaro 5mg KwikPen

Salt Composition

Eli Lilly and Company India Pvt Ltd

Cold Chain Logistics

Fact Box of Mounjaro 5mg KwikPen

Disclaimer

mounjaro 5mg

2000+ products

Secure Payment

Easy Return